61.   Bristol-Myers said it has no other patent rights elsewhere in Africa involving AIDS therapies.

62.   Bristol-Myers Squibb Co. said it would sell two AIDS medications below cost and waive their patent rights in Africa for one of the medications.

63.   Bristol-Myers has no other patent rights in Africa that could prevent AIDS therapies from being distributed.

64.   Bristol-Myers said it remains committed to the lawsuit, but that its broad defense of patent rights should not be barrier to addressing the AIDS crisis.

65.   But last year, the university revoked patent rights on the drug and said the drug can be produced by any company that wishes to.

66.   But some progress was reported on the crucial area of whether poor countries can violate patent rights on Western medicines to protect public health.

67.   But the drug companies also want to protect their patent rights against competition from cheaper generic versions.

68.   Costs would be increased by the need to license and buy patent rights, while manufacturing costs would depend on the vaccine design, Johnston said.

69.   Developing countries have called on the World Trade Organization to overrule pharmaceutical patent rights on drugs in circumstances that constitute a health emergency.

70.   Drugs companies, for their part, have warned that research and development on AIDS and HIV drugs could slow or stop if patent rights are unprotected.